| abstract |
A lipoxygenase inhibitor composition comprising as active ingredient a lipoxygenase inhibiting effective amount of a substituted styrene derivative having formulawherein X represents a hydroxyl group or a lower alkoxy group having 1 to 4 carbon atoms, q is an integer of 2 or 3; and R<sub>2</sub> and R<sub>3</sub> each represents a hydrogen atom, a lower alkoxy group or a hydroxyl group and Z represents a radical of the formula, -O-(CH<sub>2</sub>)<sub>n</sub>-CH=CH-, -NH-(CH<sub>2</sub>)<sub>n</sub>-, wherein n is an integer of 1 to 4, and a pharmaceutically acceptable carrier. |